StocksMedium•7 November 2026•
1 min read
Hims & Hers Partners with Eli Lilly to Offer FDA-Approved Obesity Drugs
Key Facts
1Hims & Hers Health announced a partnership with Eli Lilly to offer Zepbound and Foundayo on its platform.
2Foundayo is priced at $149 per month, while Zepbound is available for $299 per month.
Hims & Hers Health announced a partnership with Eli Lilly to offer FDA-approved obesity drugs Zepbound and Foundayo on its platform. Yahoo Finance Singapore reported that Foundayo is priced at $149 per month, while Zepbound is available for $299 per month.
HIMS closed at $26 on November 6, 2026, after trading between a day low of $24.41 and a high of $26.24. During the same session, LLY closed at $1354 on November 6, 2026, reaching an intraday high of $1377.27.